[Clinical evaluation of a new preparation with liver-protective and anti-anemic action].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy*; D002794:Choline / Q000627:therapeutic use*; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use*; D006432:Hemochromatosis / Q000188:drug therapy*; D006801:Humans; D006885:Hydroxybutyrates / Q000627:therapeutic use*; D008107:Liver Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000627:therapeutic use*; D010756:Phosphoric Acids / Q000627:therapeutic use*; D011736:Pyridoxine / Q000627:therapeutic use*; D014805:Vitamin B 12 / Q000627:therapeutic use*
D006885:Hydroxybutyrates; D010756:Phosphoric Acids; D009536:Niacinamide; D005492:Folic Acid; D011736:Pyridoxine; D002794:Choline; D014805:Vitamin B 12
Valutazione clinica di un nuovo preparato ad azione epatoprotettiva ed antianemica.